FDA Orders Manufacturers of Surgical Mesh for Transvaginal Repair to Stop Selling Product
- Food and Drug Administration
- All Healthcare Organizations
The U.S. Food and Drug Administration (FDA) has ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to stop selling and distributing their products in the U.S. immediately. The order is the latest in a series of escalating safety actions related to protecting the health of the thousands of women each year who undergo surgery transvaginally to repair POP.
The FDA has determined that the manufacturers, Boston Scie…